Moeldoko Asks Society To Discipline Health Protocols In Tourist Places

Presidential Chief of Staff (KSP) Moeldoko during a media briefing in Malang City, East Java, Friday (12/11/2021). (Photo: Antara)

JAKARTA - Presidential Chief of Staff (KSP) Moeldoko asked the public to remain disciplined in implementing health protocols, especially when visiting tourist attractions, because until now the COVID-19 pandemic has not ended. In a media briefing to the media in Malang, East Java, Friday , Moeldoko said that based on the results of monitoring carried out by the Coordinating Ministry for Maritime Affairs and Investment, it was found that many people were starting to ignore health protocols. "For tourism, it was discussed at the cabinet meeting. there is evidence that people are starting to ignore health protocols," he said. Moeldoko explained, actually the government wants people to be able to strictly implement health protocols, especially related to the application of the PeduliLindungi application. to use the app because CareProtect. This is suspected to be due to several factors. "Is it because maybe a different cellphone, or not understanding how to operate it, or something else. But actually the government wants people to follow PeduliLindungi," he said.

He added, the government really understands that the tourism sector is one sector that can quickly rise if the COVID-19 pandemic ends. At this time, people have felt boredom due to the COVID-19 pandemic. "This (tourism) can really move. Because actually, if the tourism sector is normal, this is the fastest moving sector. All people are tired of staying at home. "Based on records, so far in Indonesia there have been 4,249,758 positive confirmed cases of COVID-19. Of the total, 4,096,664 people were reported to have recovered and 143,608 people died. As for the achievement of vaccination, nationally there are 208,265,720 vaccination targets in Indonesia. Until now, there were 128,147,345 residents who had received the first dose of injection and 81,711,099 residents for the second dose.